Plasma Level of hsa-miR-619-5p microRNA Is Associated with Prostatic Cancer Dissemination beyond the Capsule
- 作者: Shkurnikov M.Y.1,2, Makarova Y.A.1, Knyazev E.N.1,2, Fomicheva K.A.2, Galatenko A.V.1, Nyushko K.M.2, Galatenko V.V.1, Vechorko V.I.3, Alekseev B.Y.2
- 
							隶属关系: 
							- BioClinicum Research Centre
- P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
- Federal Research Institute of Health Organization and Informatics, Ministry of Health of the Russian Federation
 
- 期: 卷 163, 编号 4 (2017)
- 页面: 475-477
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/239002
- DOI: https://doi.org/10.1007/s10517-017-3831-x
- ID: 239002
如何引用文章
详细
Profiles of circulating microRNA in the plasma of patients with prostate cancer with pathomorphological stages pT2, pT3, and pT4 are analyzed. The level of circulating microRNA hsa-miR-619-5p is elevated in patients with extracapsular spreading of the tumor, increasing significantly from stage pT2 to stage pT4.
作者简介
M. Shkurnikov
BioClinicum Research Centre; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
							编辑信件的主要联系方式.
							Email: mshkurnikov@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow; Moscow						
Yu. Makarova
BioClinicum Research Centre
														Email: mshkurnikov@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
E. Knyazev
BioClinicum Research Centre; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
														Email: mshkurnikov@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow; Moscow						
K. Fomicheva
P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
														Email: mshkurnikov@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
A. Galatenko
BioClinicum Research Centre
														Email: mshkurnikov@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
K. Nyushko
P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
														Email: mshkurnikov@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
V. Galatenko
BioClinicum Research Centre
														Email: mshkurnikov@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
V. Vechorko
Federal Research Institute of Health Organization and Informatics, Ministry of Health of the Russian Federation
														Email: mshkurnikov@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
B. Alekseev
P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia
														Email: mshkurnikov@gmail.com
				                					                																			                												                	俄罗斯联邦, 							Moscow						
补充文件
 
				
			 
						 
						 
					 
						 
						 
				 
  
  
  
  
  电邮这篇文章
			电邮这篇文章  开放存取
		                                开放存取 ##reader.subscriptionAccessGranted##
						##reader.subscriptionAccessGranted## 订阅存取
		                                		                                        订阅存取
		                                					